FFG
SPPI

Ford Financial Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Ford Financial Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed – – 552
2021
Q4 		$0 Buy
+200
New +$358 ﹤0.01% 546
2021
Q3 		– Sell
-200
Closed – – 599
2021
Q2 		$0 Buy
+200
New +$695 ﹤0.01% 614

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Ford Financial Group's SPPI Position: Q1 2022 in Review

Ford Financial Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 200 shares.

Ford Financial Group first reported a position in SPPI in Q2 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Ford Financial Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Ford Financial Group sold 200 Spectrum Pharmaceuticals Inc shares in Q1 2022.
  • Ford Financial Group first reported a position in Spectrum Pharmaceuticals Inc in Q2 2021 and held it in 2 quarters.
  • Ford Financial Group's Spectrum Pharmaceuticals Inc position peaked at $0 in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Ford Financial Group's 13F filing for Q1 2022, filed 13 Apr 2022.